Omalizumab for the treatment of chronic inducible urticaria in 80 patients

Autor:	Ana Giménez-Arnau, S. Gómez Armayones, N. Fernández Chico, Gemma Melé-Ninot, I. Figueras Nart, A. Sala Cunill, Moises Labrador-Horrillo, A. Guilabert Vidal, J. Spertino, E Serra-Baldrich, P. Aguilera Peiro, Laia Curto-Barredo, C. Baliu-Piqué, V. Expósito-Serrano, M. Bonfill Ortí
Rok vydání:	2020
Předmět:	medicine.medical_specialty Urticaria business.industry MEDLINE Omalizumab Dermatology Treatment Outcome Anti-Allergic Agents Chronic Disease Humans Medicine Chronic Urticaria business medicine.drug
Zdroj:	British Journal of Dermatology. 184:167-168
ISSN:	1365-2133 0007-0963
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c946f32a139803395a2b1f79daa6a43b https://doi.org/10.1111/bjd.19425 Zobrazit plný text záznamu Plný text